Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity

Clinical Microbiology and Infection

Volumn 20, Issue 6, 2014, Pages

  Zhang, J ^a   Zhang, X F ^b   Zhou, C ^c   Wang, Z Z ^d   Huang, S J ^a   Yao, X ^c   Liang, Z L ^c   Wu, T ^a   Li, J X ^b   Yan, Q ^a   Yang, C L ^d   Jiang, H M ^d   Huang, H J ^e,f   Xian, Y L ^e   Shih, J W K ^a   Ng, M H ^a   Li, Y M ^d,e   Wang, J Z ^c   Zhu, F C ^b   Xia, N S ^a  

^a XIAMEN UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^d Dongtai Centre for Disease Control and Prevention   (China)

^e Xiamen Innovax Biotech Company Ltd   (China)

^f Xiamen Siming District Center for Disease Control and Prevention   (China)

Author keywords

Antibody level; Hepatitis E virus; Immunity; Infection; Vaccine

Indexed keywords

HECOLIN; HEPATITIS B VACCINE; HEPATITIS E ANTIBODY; HEPATITIS E VACCINE; PLACEBO; UNCLASSIFIED DRUG; HEPATITIS VACCINE; RECOMBINANT VACCINE;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; ASYMPTOMATIC INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEPATITIS E; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOGENICITY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIMARY INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFECTION; SEROCONVERSION; SEROPREVALENCE; COHORT ANALYSIS; FOLLOW UP; HEPATITIS E VIRUS; IMMUNOLOGY; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

HEPATITIS E VIRUS;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; MIDDLE AGED; PLACEBOS; RISK ASSESSMENT; VACCINES, SYNTHETIC; VIRAL HEPATITIS VACCINES; YOUNG ADULT;

EID: 84904410410     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12419     Document Type: Article

References (27)

1. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709.
2. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.
3. Kamar N, Selves J, Mansuy JM et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-817.
4. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361: 1025-1027.
5. Teshale EH, Howard CM, Grytdal SP et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis 2010; 16: 126-129.
6. Guthmann JP, Klovstad H, Boccia D et al. A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis 2006; 42: 1685-1691.
7. Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991; 26(Suppl 3): 135-138.
8. Dalton HR, Fellows HJ, Gane EJ et al. Hepatitis E in New Zealand. J Gastroenterol Hepatol 2007; 22: 1236-1240.
9. Ijaz S, Arnold E, Banks M et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005; 192: 1166-1172.
10. Mansuy JM, Abravanel F, Miedouge M et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009; 44: 74-77.
11. Goel A, Aggarwal R. Hepatitis E: another effective vaccine, but will it make a difference? Natl Med J India 2011; 24: 30-32.
12. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147: 28-33.
13. Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 2009; 16: 519-523.
14. Boccia D, Guthmann JP, Klovstad H et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 2006; 42: 1679-1684.
15. Kumar Acharya S, Kumar Sharma P, Singh R et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46: 387-394.
16. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369: 1260.
17. Zhang S, Wang J, Yuan Q et al. Clinical characteristics and risk factors of sporadic Hepatitis E in central China. Virol J 2011; 8: 152.
18. Shrestha MP, Scott RM, Joshi DM et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903.
19. Zhu FC, Zhang J, Zhang XF et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
20. Zhou C, Huang WJ, Yao X et al. Evaluation of the diagnostic kits for hepatitis E and establishment of a quantification method for detecting anti-HEV IgG. Chin J Microbiol Immunol 2009; 29: 4.
21. Huang S, Zhang X, Jiang H et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One 2010; 5: e13560.
22. Li RC, Ge SX, Li YP et al. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 2006; 12: 1682-1688.
23. Zheng Y, Ge S, Zhang J et al. Swine as a principal reservoir of hepatitis E virus that infects humans in eastern China. J Infect Dis 2006; 193: 1643-1649.
24. Li SW, Zhang J, Li YM et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23: 2893-2901.
25. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367: 1237-1244.
26. Clayson ET, Shrestha MP, Vaughn DW et al. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis 1997; 176: 763-766.
27. Matsubayashi K, Kang JH, Sakata H et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48: 1368-1375.